1. EMA Priority Medicines scheme (PRIME): will more paying-for-performance agreements be needed due to immature data?

   • F. Antoñanzas
   • C. A. Juárez-Castelló
   • R. Rodríguez-Ibeas

   Editorial 29 November 2017 Pages: 905 - 907

2. The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study

   • Wei Yang
   • Heather Gage
   • Monique Raats

   Original Paper Open access 06 November 2017 Pages: 909 - 922

   

3. Health care service utilization of documented and undocumented hired farmworkers in the U.S.

   • Tianyuan Luo
   • Cesar L. Escalante

   Original Paper 16 November 2017 Pages: 923 - 934

   

4. Ebola in the Netherlands, 2014–2015: costs of preparedness and response

   • Anita W. M. Suijkerbuijk
   • Corien M. Swaan
   • Wilhelmina L. M. Ruijs

   Original Paper 17 November 2017 Pages: 935 - 943

   

5. The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacement

   • Aida Ribera
   • John Slof
   • David García-Dorado

   Original Paper 23 November 2017 Pages: 945 - 956

   

6. Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation

   • Maartje S. Jacobs
   • Lisa A. de Jong
   • Marinus van Hulst

   Original Paper Open access 27 November 2017 Pages: 957 - 965

   

7. The effect of online gambling on gambling problems and resulting economic health costs in Germany

   • Tobias Effertz
   • Anja Bischof
   • Ulrich John

   Original Paper 23 January 2018 Pages: 967 - 978

   

8. Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review

   • Lidia García-Pérez
   • Renata Linertová
   • Pedro Serrano-Aguilar

   Original Paper 16 December 2017 Pages: 979 - 991

   

9. Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study

   • Lisanne I. van Lier
   • Judith E. Bosmans
   • Henriëtte G. van der Roest

   Original Paper Open access 19 December 2017 Pages: 993 - 1008

10. Assessing the opportunity costs of patients with multidrug-resistant organisms in hospitals

    • Claudia Hübner
    • Walter Ried
    • Steffen Flessa

    Original Paper 15 December 2017 Pages: 1009 - 1017

    

11. Threshold analysis in the presence of both the diagnostic and the therapeutic risk

    • Stefan Felder
    • Thomas Mayrhofer

    Original Paper 26 December 2017 Pages: 1019 - 1026

    

12. Impact of specialist rehabilitation services on hospital length of stay and associated costs

    • A. Duarte
    • C. Bojke
    • G. Richardson

    Original Paper Open access 27 December 2017 Pages: 1027 - 1034